105,313 Shares in Humana Inc. (NYSE:HUM) Bought by Raymond James Financial Inc.

Raymond James Financial Inc. purchased a new stake in shares of Humana Inc. (NYSE:HUM - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 105,313 shares of the insurance provider's stock, valued at approximately $26,720,000. Raymond James Financial Inc. owned approximately 0.09% of Humana as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Vanguard Group Inc. grew its holdings in shares of Humana by 15.8% in the 4th quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider's stock worth $3,254,899,000 after acquiring an additional 1,751,857 shares during the last quarter. Norges Bank acquired a new position in shares of Humana in the 4th quarter valued at $416,202,000. Pzena Investment Management LLC increased its stake in Humana by 44.0% in the 4th quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock worth $915,736,000 after purchasing an additional 1,103,132 shares in the last quarter. Boston Partners boosted its holdings in shares of Humana by 435.8% in the fourth quarter. Boston Partners now owns 1,098,702 shares of the insurance provider's stock worth $279,236,000 after buying an additional 893,637 shares during the period. Finally, Invesco Ltd. boosted its stake in Humana by 29.8% in the 4th quarter. Invesco Ltd. now owns 2,397,808 shares of the insurance provider's stock worth $608,348,000 after purchasing an additional 550,692 shares during the period. Institutional investors and hedge funds own 92.38% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on HUM. Cantor Fitzgerald reaffirmed a "neutral" rating and set a $290.00 price objective on shares of Humana in a research report on Wednesday, February 12th. JPMorgan Chase & Co. lowered their price target on shares of Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a report on Tuesday, February 18th. Mizuho increased their price objective on Humana from $305.00 to $316.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. Robert W. Baird lifted their price objective on Humana from $270.00 to $300.00 and gave the company a "neutral" rating in a research report on Tuesday, April 15th. Finally, Piper Sandler upped their target price on Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a research report on Wednesday, January 15th. Seventeen research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to MarketBeat, Humana currently has an average rating of "Hold" and a consensus target price of $284.90.

Humana Trading Up 2.3 %

HUM stock traded up $5.92 during trading on Wednesday, hitting $264.84. The company had a trading volume of 260,617 shares, compared to its average volume of 1,754,049. The firm has a 50-day moving average price of $265.74 and a 200-day moving average price of $270.19. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The stock has a market cap of $31.96 billion, a price-to-earnings ratio of 26.62, a PEG ratio of 2.05 and a beta of 0.62.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. As a group, analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.34%. The ex-dividend date is Friday, June 27th. Humana's dividend payout ratio (DPR) is 35.58%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.